Farmed Italy Bisferr ++ Dietary supplement Description Food supplement in orastomeric release bags based on FERNANO , innovative raw material made up of ultramicronised microencapsulated bisglycinate iron. The product contains 30 mg of iron each sachet. Iron contributes to the normal cognitive function, to normal energy metabolism, to the normal formation of red blood cells and hemoglobin, to the normal transport of oxygen in the body, to the abnormal function of the immune system, to the reduction of tiredness and fatigue. in the process of cell division. Bisferr ++, thanks to the sophisticated technology of FERNANO, contains microcomponents of ultramicronized bisglycinate iron that allow the release of iron only at the level of the intestinal tract, ensuring: - high intestinal absorption and bioavailability of iron, an advantage obtained through the dimensional reduction of the microencapsulated by means of ULTRAMICRO technology; - greater digestibility and excellent tolerability. Benefit guaranteed by the microencapsulation process that protects the iron from a polymer membrane and avoids gastrointestinal problems, eliminates the aftertaste and the metallic odor. Ingredients FERNANO (microencapsulated ultramicronized bisglycinate iron); sweeteners: mannitol, sucralose; acidifier: citric acid; aroma; anti-caking agent: silicon dioxide. Nutritional characteristics 214 Average contents for 1 sachet VNR * Iron 30 mg * VNR = Reference Nutrient Value. How to use We recommend taking 1 sachet per day directly in the mouth. Warnings Supplements are not intended as a substitute for a varied, balanced diet and healthy lifestyle. Do not exceed the recommended daily dose. Keep out of reach of children under 3 years of age. Excessive consumption can have laxative effects. storage Keep in a cold and dry place. Format 14 sachets of 1.5 g. Net weight: 21 g. Cod. 942142074 Bibliography: Iron monograph. Pdr tor Nutrional supplement, First Edition. Thomson POR Staff. 2001.pp 235-240. Iron monograph. POR Nutritional Supplements. New edition. s. Hendler, either. Jorvik. 2010. pp 247-253. Opinion of the Scientific Committee / Scientific Panel. Ironand contribution to the normal function of the immune system: evaluation of a healthclaim pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal 2016; 14 (7): 4548 [8 pp]. M. Auerbach, H. Ballard, JR Trout, M. Mcllwain, A. Ackerman. H. Bahrain, et al. lntravenous Iron optimizes the Response to Recombinant Human Erythropoietin in Cancer Patients With hemotherapy-Related Anemia: A Multicenter. Open-Label. RandomizedTrial. J Clin Oncol. 2004; 22 (7): 1301-7. s. Samman. Iron. Nutrition & Oletetics 2007; 64 (Suppl. 4): S126- S130. JL Spivak, P. Gasc6n, H. Ludwig. Anemia Management InOncology And Hematology. The Oncologist 2009; 14 (Suppl. 1): 43-56www.theoncologist.com.